Stock Price Quote

PARABOLIC DRUGS LTD.

NSE : PARABDRUGSBSE : 533211ISIN CODE : INE618H01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE5.700 (0 %)
PREV CLOSE ( ) 5.70
OPEN PRICE ( ) 5.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 21
TODAY'S LOW / HIGH ( )5.70 5.70
52 WK LOW / HIGH ( )5.7 5.7
NSE5.500 (0 %)
PREV CLOSE( ) 5.50
OPEN PRICE ( ) 5.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 5.50 (24000)
VOLUME 123
TODAY'S LOW / HIGH( ) 5.50 5.50
52 WK LOW / HIGH ( )5.5 5.5
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 22-02 1996
Management Info
- Chairman Pranav Gupta - Managing Director
Registered Office

Address S. C. O 186-187,2nd Floor,Sector 8 C,
Chandigarh,
Union Territory-160008

Phone 0172-4182800

Email NA

Website www.parabolicdrugs.com

Registrars Details
Link Intime India Pvt Ltd.
Narang Tower 44, Community Centre,Naraina Industrial Area ,Phase - 1,New Delhi
Listing : BSE, NSE, MCX

NEWS

16Jun Parabolic Drugs informs about certific
Pursuant to Regulation 40(9) of SEBI (Listing Obligations and Disclosure..
10Apr Parabolic Drugs informs about CoC meet
Parabolic Drugs has informed about outcome of seventh meeting of Committ..
07Mar Parabolic Drugs informs about CoC meet
Pursuant to the provisions of Regulations 17, 19 and 20 of the IBBI (Ins..
05Jan Parabolic Drugs informs about CoC meet
Pursuant to the provisions of Regulations 17, 19 and 20 of the IBBI (Ins..
27Nov Parabolic Drugs informs about CoC meet
Pursuant to the provisions of Regulations 17, 19 and 20 of the IBBI (Ins..

Financials

in Millions
QTR Dec 20 ANNUAL 20
Net Profit-0.61-286.4
Gross Profit -0.61 -286.4
Operating Profit -0.07-63.9
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE)
peergroup  6660.85 (7.79%)
M.Cap ( in Cr)8545.80
Concord Biotech (BSE)
peergroup  1561.65 (3.68%)
M.Cap ( in Cr)16337.39
Sanofi India (BSE)
peergroup  8490.90 (0.51%)
M.Cap ( in Cr)19555.07
JB Chem & Pharma (BSE)
peergroup  1800.50 (2.37%)
M.Cap ( in Cr)27942.82
Divi's Lab (BSE)
peergroup  3779.20 (1.08%)
M.Cap ( in Cr)100325.89

Shareholding Pattern

NON-INSTITUTION 53.57%
PROMOTERS 37.79%
FI/BANKS/INSURANCE 0.57%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Parabolic Drugs Ltd.

Parabolic Drugs Ltd. was incorporated in the year 1996. Its today's share price is 5.7. Its current market capitalisation stands at Rs 35.28 Cr. In the latest quarter, company has reported Gross Sales of Rs. 726 Cr and Total Income of Rs.767.05 Cr. The company's management includes Vandana Singla, Jagjit Singh Chahal, Sanjeev Kumar, Vineet Gupta, Pranav Gupta.

It is listed on the BSE with a BSE Code of 533211 , NSE with an NSE Symbol of PARABDRUGS and ISIN of INE618H01016. It's Registered office is at S. C. O 186-187,2nd Floor,Sector 8 CChandigarh-160008, Union Territory. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are SK Bansal & Co, VK Jindal & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.